Sertraline Hydrochloride Patent Expiration
Sertraline Hydrochloride is Used for treating disorders of the serotonergic system such as depression and anxiety-related disorders. It was first introduced by Viatris Specialty Llc
Sertraline Hydrochloride Patents
Given below is the list of patents protecting Sertraline Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zoloft |
US6727283 (Pediatric) | Sertraline oral concentrate |
Apr 11, 2020
(Expired) | Viatris |
| Zoloft |
US7067555 (Pediatric) | Sertraline oral concentrate |
Apr 11, 2020
(Expired) | Viatris |
| Zoloft | US6727283 | Sertraline oral concentrate |
Oct 11, 2019
(Expired) | Viatris |
| Zoloft | US7067555 | Sertraline oral concentrate |
Oct 11, 2019
(Expired) | Viatris |
| Zoloft |
US5248699 (Pediatric) | Sertraline polymorph |
Feb 13, 2013
(Expired) | Viatris |
| Zoloft | US5248699 | Sertraline polymorph |
Aug 13, 2012
(Expired) | Viatris |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Sertraline Hydrochloride's patents.
Latest Legal Activities on Sertraline Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Sertraline Hydrochloride.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Nov, 2017 | US7067555 |
| Patent Issue Date Used in PTA Calculation Critical | 27 Jun, 2006 | US7067555 |
| Recordation of Patent Grant Mailed Critical | 27 Jun, 2006 | US7067555 |
| Issue Notification Mailed Critical | 07 Jun, 2006 | US7067555 |
| Dispatch to FDC | 01 Jun, 2006 | US7067555 |
| Application Is Considered Ready for Issue Critical | 04 May, 2006 | US7067555 |
| Mail Examiner's Amendment | 17 Apr, 2006 | US7067555 |
| Pubs Case Remand to TC Critical | 13 Jan, 2006 | US7067555 |
| Issue Fee Payment Received Critical | 07 Nov, 2005 | US7067555 |
| Issue Fee Payment Verified Critical | 07 Nov, 2005 | US7067555 |
Sertraline Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Sertraline Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Sertraline Hydrochloride. The first generic version for Sertraline Hydrochloride was by Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa and was approved on Jun 30, 2006. And the latest generic version is by Ascent Pharmaceuticals Inc and was approved on May 3, 2021.
Given below is the list of companies who have filed for Sertraline Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Nov 7, 2014 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Nov 7, 2014 |
| EQ 25MG BASE | tablet | Prescription | ORAL | AB | Nov 7, 2014 |
2. ANDA REPOSITORY
Anda Repository Llc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Anda Repository.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
3. APPCO
Appco Pharma Llc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Appco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
Manufacturing Plant Locations New
Appco's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Appco as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
4. ASCENT PHARMS INC
Ascent Pharmaceuticals Inc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | May 3, 2021 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | May 3, 2021 |
| EQ 25MG BASE | tablet | Prescription | ORAL | AB | May 3, 2021 |
5. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
| EQ 20MG BASE/ML | concentrate | Prescription | ORAL | AA | Oct 31, 2008 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
6. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
7. GRANULES
Granules India Ltd has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Granules.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Jan 8, 2008 |
| EQ 25MG BASE | tablet | Prescription | ORAL | AB | Jan 8, 2008 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Jan 8, 2008 |
Manufacturing Plant Locations New
Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||
| India |
| |||||||||||
8. HERITAGE PHARMA AVET
Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Heritage Pharma Avet.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
9. HIKMA PHARMS
Hikma Pharmaceuticals has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Aug 10, 2009 |
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Aug 10, 2009 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Aug 10, 2009 |
10. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Invagen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
11. IVAX SUB TEVA PHARMS
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Jun 30, 2006 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Jun 30, 2006 |
| EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Jun 30, 2006 |
12. LUPIN
Lupin Ltd has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Lupin.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
Manufacturing Plant Locations New
Lupin's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Lupin as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||||||||||||
| United States |
| |||||||||||||||||||||||||||||
13. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Mar 20, 2007 |
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Mar 20, 2007 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Mar 20, 2007 |
14. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Jan 31, 2008 |
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Jan 31, 2008 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Jan 31, 2008 |
15. OXFORD PHARMS
Oxford Pharmaceuticals Llc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Oxford Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Prescription | ORAL | AB | Jul 21, 2010 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Jul 21, 2010 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Jul 21, 2010 |
16. RANBAXY LABS LTD
Ranbaxy Laboratories Ltd has filed for 1 generic for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Ranbaxy Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE/ML | concentrate | Discontinued | ORAL | N/A | Feb 5, 2007 |
17. REYOUNG
Reyoung Corporation has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Reyoung.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Mar 4, 2009 |
| EQ 25MG BASE | tablet | Prescription | ORAL | AB | Mar 4, 2009 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Mar 4, 2009 |
18. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Prescription | ORAL | AB | Apr 30, 2007 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Apr 30, 2007 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Apr 30, 2007 |
19. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 4 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE/ML | concentrate | Prescription | ORAL | AA | Jun 30, 2006 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
| EQ 25MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||
20. SUN PHARM INDS (IN)
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds (in).
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
21. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 5 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 150MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 200MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
22. TORRENT PHARMS
Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Torrent Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
23. VIWIT PHARM
Viwit Pharmaceutical Co Ltd has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Viwit Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Feb 6, 2007 |
Manufacturing Plant Locations New
Viwit Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Viwit Pharm as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| China |
| |||
24. ZYDUS
Zydus Worldwide Dmcc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2007 |
Manufacturing Plant Locations New
Zydus's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Zydus as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||||||
| United States |
| |||||||||||||||||||||||